The novel hybrid polycarbonate polyurethane / polyester three-layered large-diameter artificial blood vessel

Abstract

Background The most common materials of artificial blood vessels are polyethylene terephthalate and polytetrafluoroethylene. But polycarbonate polyurethane (PCU) is an ideal material for vascular prostheses because of their excellent characteristics. As far as we know, our artificial blood vessel is the first type of hybrid PCU/polyester three-layered large-diameter artificial blood vessel in the world. Objective The purpose of this preclinical animal experiment is to evaluate the hemocompatibility, histocompatibility, effectiveness, and safety of the three-layered large-diameter artificial blood vessel in sheep. Methods The artificial blood vessels took place of the initial segments of the sheep’s thoracic aorta by end-to-end anastomosis. Results All of the 14 sheep are male, their average body weight (BW) was 30.57 ± 3.95 kg. All 14 artificial blood vessels successfully replaced the thoracic aortas. 5 sheep did not survive to the end of the experiment, while the remaining 9 sheep did. After the surgery, the blood biochemical and blood routine indicators fluctuate slightly within the normal range. The angiography showed that the implanted artificial blood vessels were unobstructed without obvious stenosis or expansion. 24 weeks after surgery, the lumen surfaces of the artificial blood vessels were covered by endothelia in different degrees, and the average endothelialization rate was 69.44% (range: 20% to 100%). Conclusions This artificial blood vessel is the first to use PCU in large-diameter artificial vascular grafts. It has excellent blood compatibility, wonderful biocompatibility, high endothelialization rate, and 100% patency.

Visual analysis of abdominal aortitis treatment using the CiteSpace bibliometric method

“…If not treated properly or in time, abdominal aortitis can induce aneurysms[ 3 ], and the resulting rupture of aneurysms can lead to organ ischemia, which is the third cause of sudden death after myocardial infarction and stroke[ 4 ]. Recent studies demonstrated that glucocorticoids (prednisone and methylprednisolone), immunosuppressants (azathioprine and cyclophosphamide), and surgery (such as aortic artificial vascular replacement) have significant effects on the treatment of abdominal aortitis[ 5 ].…”